about
Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract SurgeryResearch Findings on Overactive BladderTreating Diabetic Neuropathy: Present Strategies and Emerging Solutions.A comprehensive review of urologic complications in patients with diabetes.Diabetic bladder dysfunction.OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes.Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasNovel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.Neurogenic Bladder Repair Using Autologous Mesenchymal Stem Cells.Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat.Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus.Does concomitant diabetes affect treatment responses in overactive bladder patients?Integrative analysis of super enhancer SNPs for type 2 diabetes.Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study.Purinergic signalling underlies transforming growth factor-β-mediated bladder afferent nerve hyperexcitability.The change of signaling pathway on the electrical stimulated contraction in streptozotocin-induced bladder dysfunction of rats
P2860
Q26749608-229FF92E-328D-4F53-B0D4-C7A055E318B4Q26801459-2A49C4BA-6AF3-4861-9434-7F118F825348Q33583006-3D0D2AAE-BD14-4BB8-8719-D62830B28FD9Q34283239-1AFD9201-2CA2-4E5C-83CB-E190A64D6618Q35591952-08AFA32E-5E40-41AB-A8F9-3F238280809FQ38669033-AC85C063-234F-403F-B85A-7821856FB34FQ39369013-ABA51899-C3A8-4ECF-9B03-18E9C8CA99D5Q40615541-FBE0A9DB-85F4-4E0E-B2B4-B5A179C531F3Q40982063-FF68BFC8-94E9-47A3-B935-1456EF25ECC6Q41079882-D11E7BCE-D386-40DA-9F83-1FFF451FFF6EQ41385505-7E772E82-FE03-4766-A2F3-B3DCA7B3D885Q43472299-E904D972-3812-4D11-B347-4A39374E7D8FQ45916219-4698E58F-0901-486C-834D-4FDA3A2D2E12Q46189177-5FF82750-FC02-4198-9D34-DF16FC9454DDQ48133244-643C407A-9003-42E7-848A-CC320B2262F5Q52612613-15AC8138-F36A-4565-B081-C8BE806EA852Q54205799-60CFA030-F9AC-499C-96C8-CD3CBE820815Q58700972-7ABB6389-48F2-4036-A5E4-B85728042020
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bladder dysfunction in diabetes mellitus.
@ast
Bladder dysfunction in diabetes mellitus.
@en
type
label
Bladder dysfunction in diabetes mellitus.
@ast
Bladder dysfunction in diabetes mellitus.
@en
prefLabel
Bladder dysfunction in diabetes mellitus.
@ast
Bladder dysfunction in diabetes mellitus.
@en
P2860
P356
P1476
Bladder dysfunction in diabetes mellitus.
@en
P2093
Ismail Laher
Saeid Golbidi
P2860
P356
10.3389/FPHAR.2010.00136
P577
2010-11-16T00:00:00Z